BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-4029 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-4029\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07739160-11093@assetmemo.bio
DTSTAMP:20261121T005657Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:HRS-4029: Phase 2 readout est. (NCT07739160)
DESCRIPTION:HRS-4029\, phase 2\, Acute Ischemic Stroke.\nStudy: The Efficac
 y and Safety of HRS-4029 in Acute Ischemic Stroke Patients\nEstimated prim
 ary completion: April 2027. This is a ClinicalTrials.gov estimate\, not a 
 confirmed readout date\, and it can move.\nDrug page: https://assetmemo.bi
 o/drug/hrs-4029#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT07739160
URL:https://assetmemo.bio/drug/hrs-4029#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
